75 related articles for article (PubMed ID: 20516454)
1. Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factor.
Damm F; Lange K; Heuser M; Oberacker T; Morgan M; Wagner K; Krauter J; Schlegelberger B; Ganser A; Göhring G
J Clin Oncol; 2010 Aug; 28(22):e384-7; author reply e388-9. PubMed ID: 20516454
[No Abstract] [Full Text] [Related]
2. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L
J Clin Oncol; 2009 Feb; 27(5):782-90. PubMed ID: 19114693
[TBL] [Abstract][Full Text] [Related]
3. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.
Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L
Int J Mol Med; 2006 Aug; 18(2):267-71. PubMed ID: 16820933
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes.
Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Martelli AM; Cocco L
Leukemia; 2011 Feb; 25(2):271-80. PubMed ID: 21109771
[TBL] [Abstract][Full Text] [Related]
5. Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.
Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccarani M; Martelli AM; Manzoli L; Martinelli G; Cocco L
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16811-6. PubMed ID: 19805378
[TBL] [Abstract][Full Text] [Related]
6. Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia.
Lo Vasco VR; Calabrese G; Manzoli L; Palka G; Spadano A; Morizio E; Guanciali-Franchi P; Fantasia D; Cocco L
Leukemia; 2004 Jun; 18(6):1122-6. PubMed ID: 15085153
[TBL] [Abstract][Full Text] [Related]
7. MDR1 gene expression in myelodysplastic syndrome and in acute myeloid leukemia evolving from myelodysplastic syndrome.
Zöchbauer S; Gsur A; Götzl M; Wallner J; Lechner K; Pirker R
Anticancer Res; 1994; 14(3B):1293-5. PubMed ID: 7915092
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.
Tamura H; Dan K; Yokose N; Iwakiri R; Ohta M; Sakamaki H; Tohyama K; Kondo A; Hyodo H; Nakamura K; Yamashita T; Elisseeva OA; Oka Y; Oji Y; Sugiyama H; Ogata K
Leuk Res; 2010 Aug; 34(8):986-90. PubMed ID: 20031209
[TBL] [Abstract][Full Text] [Related]
9. Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study.
Björk J; Johansson B; Broberg K; Albin M
Leuk Res; 2009 Jun; 33(6):788-91. PubMed ID: 19019430
[TBL] [Abstract][Full Text] [Related]
10. Expression of the interleukin 6 gene in acute myeloid leukemia and myelodysplastic syndromes: a report on 49 cases.
Collyn d'Hooghe M; Fenaux P; Lantoine D; Loucheux-Lefebvre M; Kerckaert JP
Nouv Rev Fr Hematol (1978); 1990; 32(3):175-7. PubMed ID: 2216700
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
[TBL] [Abstract][Full Text] [Related]
12. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
[TBL] [Abstract][Full Text] [Related]
13. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
Fuchs O; Provaznikova D; Kocova M; Kostecka A; Cvekova P; Neuwirtova R; Kobylka P; Cermak J; Brezinova J; Schwarz J; Markova J; Salaj P; Klamova H; Maaloufova J; Lemez P; Novakova L; Benesova K
Blood Cells Mol Dis; 2008; 40(3):401-5. PubMed ID: 18182175
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele.
Jaquet K; Kreipe H; Felgner J; Boultwood J; Parwaresch MR
Leukemia; 1993 Apr; 7(4):650-2. PubMed ID: 8464244
[No Abstract] [Full Text] [Related]
15. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
[TBL] [Abstract][Full Text] [Related]
16. Association with the single-nucleotide polymorphism (Glu785Lys) of the granulocyte colony-stimulating factor receptor with myelodysplastic syndromes and acute myeloid leukemia with multlineage dysplasia.
Platzbecker U; Germing U; Schäkel U; Illmer T; Soucek S; Schaich M; Ehninger G; Thiede C
Leukemia; 2006 Dec; 20(12):2188-9. PubMed ID: 17024119
[No Abstract] [Full Text] [Related]
17. Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome.
Streubel B; Valent P; Jäger U; Edelhäuser M; Wandt H; Wagner T; Büchner T; Lechner K; Fonatsch C
Genes Chromosomes Cancer; 2000 Apr; 27(4):380-6. PubMed ID: 10719368
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH.
Shali W; Hélias C; Fohrer C; Struski S; Gervais C; Falkenrodt A; Leymarie V; Lioure B; Raby P; Herbrecht R; Lessard M
Cancer Genet Cytogenet; 2006 Jul; 168(2):133-45. PubMed ID: 16843103
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia.
Benites BD; Traina F; Duarte Ada S; Lorand-Metze IG; Costa FF; Saad ST
Eur J Haematol; 2010 Jun; 84(6):525-30. PubMed ID: 20345447
[TBL] [Abstract][Full Text] [Related]
20. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome].
Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H
Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
